Results 51 to 60 of about 1,488,405 (299)

An Unusual Presentation of Extensive Ductal Carcinoma in Situ Accompanying Invasive Ductal Carcinoma on MRI: A Case Report

open access: yes대한영상의학회지, 2022
The incidence of ductal carcinoma in situ has increased with the rise in screening mammography; currently, ductal carcinoma in situ constitutes 20%–25% of all breast cancers, and up to half of them may become invasive.
Yeon Jung Kim, Hyun Kyung Jung, Woogyeong Kim
doaj   +1 more source

From energy provision to protein synthesis: Tunnelling nanotubes as mediators of intercellular metabolic cooperation in cancer

open access: yesFEBS Open Bio, EarlyView.
The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley   +1 more source

Metaplastic Carcinoma with Chondroid Differentiation Mimicking Malignant Phyllodes Tumor: A Case Report

open access: yes대한영상의학회지, 2018
Metaplastic breast carcinoma is a rare type of neoplasms with mixed epithelial and mesenchymal differentiation. Metaplastic carcinoma with chondroid differentiation is relatively an uncommon type among the different types of metaplastic carcinoma.
Leehi Joo, Soo Hyun Yeo, Sun Young Kwon
doaj   +1 more source

Invasive Ductal Carcinoma

open access: yesThe Breast Journal, 1998
The purpose of this section is to present in pictorial form the diverse clinical, radiologic, and pathologic aspects of breast disorders. Stuart J. Schnitt M.D.
Kavitha Sunku   +3 more
openaire   +1 more source

A study of the molecular pathology of ductal carcinoma in situ and invasive ductal carcinoma of the breast. [PDF]

open access: yes, 2005
The biological validity of the histopathological classification of ductal carcinoma in situ (DCIS) of the breast was evaluated in this study by correlating the three histopathological grades of DCIS to immunohistochemical expression of Ki67, p53, cerbB-2,
Rehman, S.
core  

Discrimination of invasive ductal and lobular carcinoma of the breast based on the combination of enhanced Legendre polynomial, kinetic features and deep learning features [PDF]

open access: yes
The fifth most common cause of cancer-related deaths among women worldwide is breast cancer, which is the most common cancer among women globally. Early detection of breast cancer through regular screenings and awareness of symptoms can lead to better ...
Al-Waely, N. K. N.   +5 more
core   +1 more source

The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ. [PDF]

open access: yes, 2008
Approximately 1 in every 600 women attending breast-screening programmes in the United Kingdom is diagnosed with breast carcinoma in situ (BCIS). However, there is little information on the occurrence of subsequent cancers (other than second breast ...
Holmberg, L   +9 more
core   +1 more source

LaNt α31 is upregulated in invasive ductal carcinoma.

open access: yes, 2022
Serial sections from formalin-fixed paraffin-embedded human breast tissue processed for immunohistochemistry with mouse monoclonal antibodies against laminin α3, LaNt α31, or mouse IgG- isotype control, (A) uninvolved breast tissue, (B) invasive ductal ...
Tobias Zech (47625)   +3 more
core   +1 more source

Using cell‐free RNA to identify B‐ and T‐cell clonality for diagnosis and monitoring of B‐ and T‐cell neoplasms

open access: yesFEBS Open Bio, EarlyView.
Using peripheral blood for determining B‐cell or T‐cell clonality is more reliable when we use cell‐free RNA (cfRNA) because cells release blood significantly more RNA than DNA. Next‐generation sequencing (NGS) of cfRNA allows us to evaluate fragment cfRNA and evaluate clonality reliably without the need for prior determination of the specific dominant
Adam Albitar   +11 more
wiley   +1 more source

Expression of B-cell Lymphoma 2 (BCL-2) in Breast Cancer

open access: yesJournal of Cancer and Allied Specialties, 2021
Introduction: Immunohistochemical expression of B-cell lymphoma 2 (BCL-2) is seen variably in invasive ductal carcinoma. This study was conducted to determine the frequency of BCL-2 expression in different histologic grades of invasive ductal carcinoma ...
Sehar Bashir   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy